Real-world treatments and thrombotic events in polycythemia vera patients in the USA.

"Declarations Ethics approval and consent to participateThis retrospective database analysis used de-identified data. As such, Institutional Review Board (IRB) approval to conduct this analysis was not required nor was patient consent required. This analysis complies with the Health Insurance Portability and Accountability Act of 1996 (HIPAA) and its implementing regulations of Title 45 Code of Federal Regulations Parts 160 and 164 (“HIPAA Privacy and Security Rules”). Consent for publicationAll authors consent to publication. Conflict of interestS. Verstovsek and N. Pemmaraju have received research support for conduct of clinical studies for Protagonist Therapeutics, Inc. N. Reaven, S. Funk, and F. Valone received consulting fees for work provided in support of this manuscript. T. Woody and S. Gupta are/were employees of Protagonist Therapeutics at the time of the research and/or writing phase of this manuscript. Conflict of interest S. Verstovsek and N. Pemmaraju have received research support for conduct of clinical studies for Protagonist Therapeutics, Inc. N. Reaven, S. Funk, and F. Valone received consulting fees for work provided in support of this manuscript. T. Woody and S. Gupta are/were employees of Protagonist Therapeutics at the time of the research and/or writing phase of this manuscript."

"Funding This study was supported by Protagonist Therapeutics, Inc. (Newark, CA)."